Once inside, itaconate alkylates PD-L1 at cysteine 272, preventing its ubiquitination and degradation, stabilizing PD-L1 levels on tumor cells and promoting resistance to immunotherapy [142]. The gene discussed is CD274; the disease is neoplasm.